032300 — Korea Pharma Co Share Price
0.000.00%
Last trade - 00:00- KR₩191bn
- KR₩173bn
- KR₩83bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.79 | ||
| Price to Tang. Book | 2.97 | ||
| Price to Free Cashflow | 56.21 | ||
| Price to Sales | 2.33 | ||
| EV to EBITDA | 26.79 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.21% | ||
| Return on Equity | 2.06% | ||
| Operating Margin | 4.52% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 66,136.2 | 71,509.73 | 79,576.7 | 81,029.42 | 83,240.45 | n/a | n/a | 6.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +43.54 | -41.84 | +47.22 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Korea Pharma Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medicinal products. The Company's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- December 24th, 1985
- Public Since
- August 10th, 2020
- No. of Shareholders
- 25,454
- No. of Employees
- 284
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 10,906,701
- Address
- 87, Jeyakgongdan 3-gil, Hyangnam-eup, HWASEONG, 18622
- Web
- https://www.koreapharma.co.kr/main/main.php
- Phone
- +82 313537291
- Auditors
- Daehyun Accounting Corp
Upcoming Events for 032300
Q3 2024 Korea Pharma Co Ltd Earnings Release
Similar to 032300
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
What is the Korea Pharma Co share price?
As of Today at 15:42 UTC, shares in Korea Pharma Co are trading at KR₩17,770. This share price information is delayed by 15 minutes.
How has the Korea Pharma Co share price performed this year?
Shares in Korea Pharma Co last closed at KR₩17,770 and the price had moved by -4.36% over the past 365 days. In terms of relative price strength the Korea Pharma Co share price has underperformed the FTSE Developed Asia Pacific Index by -8.48% over the past year.
What are the analyst and broker recommendations for Korea Pharma Co?
There is no consensus recommendation for this security.
What is the Korea Pharma Co dividend yield?
The Korea Pharma Co dividend yield is 0.28% based on the trailing twelve month period.
Does Korea Pharma Co pay a dividend?
Last year, Korea Pharma Co paid a total dividend of KR₩50, and it currently has a trailing dividend yield of 0.28%. We do not have any data on when Korea Pharma Co is to next pay dividends.
When does Korea Pharma Co next pay dividends?
We do not have data on when Korea Pharma Co is to next pay dividends. The historic dividend yield on Korea Pharma Co shares is currently 0.28%.
How do I buy Korea Pharma Co shares?
To buy shares in Korea Pharma Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Korea Pharma Co?
As of the previous close price of KR₩17,770, shares in Korea Pharma Co had a market capitalisation of KR₩194bn.
Where are Korea Pharma Co shares listed?
Here are the trading details for Korea Pharma Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 032300
What kind of share is Korea Pharma Co?
Based on an overall assessment of its quality, value and momentum Korea Pharma Co is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Korea Pharma Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Korea Pharma Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Korea Pharma Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -22%.
As of the last closing price of KR₩17,770, shares in Korea Pharma Co were trading -12.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Korea Pharma Co PE Ratio?
The Korea Pharma Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩17,770.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Korea Pharma Co?
We do not have data on Korea Pharma Co's directors